Literature DB >> 4820815

Ulcerative colitis, myasthenia gravis, atypical lichen planus, alopecia areata, vitiligo.

R S Tan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4820815      PMCID： PMC1645369     

Source DB:  PubMed          Journal:  Proc R Soc Med        ISSN： 0035-9157


× No keyword cloud information.
  10 in total

1.  ALOPECIA AREATA. AN EVALUATION OF 736 PATIENTS.

Authors:  S A MULLER; R K WINKELMANN
Journal:  Arch Dermatol       Date:  1963-09

2.  SYSTEMIC LUPUS ERYTHEMATOSUS FOLLOWING THYMECTOMY FOR MYSTHENIA GRAVIS. REPORT OF TWO CASES.

Authors:  D ALARCON SEGOVIA; R F GALBRAITH; J E MALDONADO; F M HOWARD
Journal:  Lancet       Date:  1963-09-28       Impact factor: 79.321

3.  The autoimmune response in myasthenia gravis.

Authors:  R G WHITE; A H MARSHALL
Journal:  Lancet       Date:  1962-07-21       Impact factor: 79.321

4.  Studies on autoantibodies in myasthenia gravis.

Authors:  E H BEUTNER; E WITEBSKY; D RICKEN; R H ADLER
Journal:  JAMA       Date:  1962-10-06       Impact factor: 56.272

5.  Myasthenia gravis, ulcerative colitis and lichen planus.

Authors:  T N Miller
Journal:  Proc R Soc Med       Date:  1971-08

6.  An unusual variant of lupus erythematosus or lichen planus.

Authors:  P W Copeman; A L Schroeter; R R Kierland
Journal:  Br J Dermatol       Date:  1970-08       Impact factor: 9.302

7.  Chronic mucocutaneous candidiasis, endocrine deficiency and alopecia areata.

Authors:  L Stankler; P D Bewsher
Journal:  Br J Dermatol       Date:  1972-03       Impact factor: 9.302

8.  On the etiology of vitiligo and gray hair.

Authors:  A B Lerner
Journal:  Am J Med       Date:  1971-08       Impact factor: 4.965

9.  Role of the thymus and related organs in immunity.

Authors:  M BURNET
Journal:  Br Med J       Date:  1962-09-29

10.  Autoantibodies in human ulcerative colitis.

Authors:  O BROBERGER; P PERLMANN
Journal:  J Exp Med       Date:  1959-11-01       Impact factor: 14.307
  10 in total
  14 in total

1.  A case of vitiligo vulgaris showing a pronounced improvement after treatment for myasthenia gravis.

Authors:  Kiyotaka Nakamagoe; Jun-Ichi Furuta; Ayako Shioya; Akira Tamaoka
Journal:  BMJ Case Rep       Date:  2009-12-09

Review 2.  Ocular myasthenia gravis and inflammatory bowel disease: a case report and literature review.

Authors:  R Foroozan; R Sambursky
Journal:  Br J Ophthalmol       Date:  2003-09       Impact factor: 4.638

3.  Alopecia totalis in a patient with Crohn's disease and its treatment with azathioprine.

Authors:  C J Goddard; P J August; P J Whorwell
Journal:  Postgrad Med J       Date:  1989-03       Impact factor: 2.401

4.  A case of isolated plexiform neurofibroma in a patient with myasthenia gravis.

Authors:  Seung Ju Back; Dae Hun Kim; Nari Kim; Young Lee; Young Joon Seo; Jang Kyu Park; Jeung Hoon Lee
Journal:  Ann Dermatol       Date:  2009-02-28       Impact factor: 1.444

5.  Alopecia areata, vitiligo, scleroderma and ulcerative colitis.

Authors:  D M Thompson; T W Robinson; J Lennard-Jones
Journal:  Proc R Soc Med       Date:  1974-10

6.  Cure of alopecia areata after eradication of Helicobacter pylori: a new association?

Authors:  Germán Campuzano-Maya
Journal:  World J Gastroenterol       Date:  2011-07-14       Impact factor: 5.742

7.  The triad of lichen planus, thymoma and liver cirrhosis-hepatoma. First reported case.

Authors:  J A Hassan; S Saadiah; A M Roslina; M Atan; N Masir; S Hussein; T Ganesapillai
Journal:  Malays J Med Sci       Date:  2000-07

8.  A rare thymoma case with seven paraneoplastic syndromes.

Authors:  Li Gong; Pei Zhang; Xue-Yuan Liu; Min Fang
Journal:  Int J Clin Exp Med       Date:  2015-10-15

Review 9.  What causes alopecia areata?

Authors:  K J McElwee; A Gilhar; D J Tobin; Y Ramot; J P Sundberg; M Nakamura; M Bertolini; S Inui; Y Tokura; L E King; B Duque-Estrada; A Tosti; A Keren; S Itami; Y Shoenfeld; A Zlotogorski; R Paus
Journal:  Exp Dermatol       Date:  2013-09       Impact factor: 3.960

10.  Hair loss with ulcerative colitis.

Authors:  D A Windsor
Journal:  J R Soc Med       Date:  1990-05       Impact factor: 18.000
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.